RaySearch Laboratories AB (publ) (FRA:27R)

Market Cap	710.24M -7.2%
Revenue (ttm)	124.22M +12.8%
Net Income	21.05M +11.9%
EPS	0.61 +11.9%
Shares Out	n/a
PE Ratio	33.74
Forward PE	28.68
Dividend	0.28 (1.33%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	106
Open	20.00
Previous Close	20.60
Day's Range	20.00 - 20.00
52-Week Range	15.74 - 32.70
Beta	n/a
RSI	67.09
Earnings Date	Apr 15, 2026

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Prepackaged Software
• Founded: 2000
• Employees: 450
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 27R

Financial Performance

In 2025, RaySearch Laboratories AB's revenue was 1.34 billion, an increase of 12.78% compared to the previous year's 1.19 billion. Earnings were 227.80 million, an increase of 11.94%.

Financial numbers in SEK